New Zealand markets closed

NRx Pharmaceuticals, Inc. (NRXP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.7184+0.0039 (+0.55%)
As of 11:29AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
Total revenue
0
0
0
Operating expenses
Research development
18,984
20,257
10,625
Selling general and administrative
68,438
74,944
11,436
Total operating expenses
87,422
94,430
11,901
Operating income or loss
-87,422
-94,430
-11,901
Interest expense
5
18
56
Total other income/expenses net
27,388
1,385
-39,820
Income before tax
-59,920
-93,063
-51,777
Income tax expense
-
0
0
Income from continuing operations
-59,920
-93,063
-51,777
Net income
-59,920
-93,063
-51,777
Net income available to common shareholders
-59,920
-348,885
-51,777
Basic EPS
-
-7.44
-1.51
Diluted EPS
-
-7.44
-1.51
Basic average shares
-
46,918
34,271
Diluted average shares
-
46,918
34,271
EBITDA
-
-93,043
-51,719